StreetAlpha.app
Home › Stocks › BSX

Boston Scientific Corp (BSX)

Healthcare
$41.98
▼ −2.35%
LAST CLOSE · NOV 20

Boston Scientific develops, makes and sells medical devices for hospitals and other health care providers. It last closed at $41.98 on Nov 20, down 2.35% on the day. The next earnings report for BSX is expected around Wed, Feb 3, 2027. For the quarter ended Sep 2026, BSX reported EPS of $0.40 on revenue of $5.14B, with revenue up 1.4% from a year ago. Over its last 8 reports the stock moved an average of 5.8% the session after earnings. Over the last 12 months BSX insiders bought $10.0M of stock on the open market and sold $16.8M, according to SEC Form 4 filings.

AI Auto Pilots
Is BSX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold BSX.

Key Stats

Last 12 months
Results
Revenue
$21.1B
+8.9% vs a year ago
Net income
$3.5B
+25.5% vs a year ago
EPS (diluted)
$2.37
+26.7% vs a year ago
Free cash flow
$3.3B
15.8% margin
Valuation
Market cap
$60.8B
1.45B shares
P/E
17.7
Price over 12 month EPS
Price to sales
2.9
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$609.0M
At Sep 30
Shareholder equity
$25.6B
Shares outstanding
1.45B
At Oct 29
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $11.9B$11.9BFY2021FY2022: $12.7B$12.7BFY2022FY2023: $14.2B$14.2BFY2023FY2024: $16.7B$16.7BFY2024FY2025: $20.1B$20.1BFY2025

From BSX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 2). Last 12 months adds up the four latest quarters.

Next report
Feb 3
Estimated date · Time not announced
Reported EPS
$0.40
Quarter ended Sep 2026
Year ago EPS
$0.51
−21.6% on a GAAP basis
Revenue
$5.14B
+1.4% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.38Dec '24Mar 2025: $0.45Mar '25Jun 2025: $0.53Jun '25Sep 2025: $0.51Sep '25Dec 2025: $0.45Dec '25Mar 2026: $0.90Mar '26Jun 2026: $0.61Jun '26Sep 2026: $0.40Sep '26Latest $0.40
Revenue by quarter
Dec 2024: $4.56BDec '24Mar 2025: $4.66BMar '25Jun 2025: $5.06BJun '25Sep 2025: $5.07BSep '25Dec 2025: $5.29BDec '25Mar 2026: $5.20BMar '26Jun 2026: $5.44BJun '26Sep 2026: $5.14BSep '26Latest $5.14B
How BSX moved after its last 8 reports
Average move the session after a report ±5.8%
Oct 28, 2026Time not announced−5.8%
Jul 29, 2026Time not announced−0.0%
Apr 22, 2026Time not announced+9.0%
Feb 4, 2026Time not announced−17.6%
Oct 22, 2025Time not announced+4.0%
Jul 23, 2025Time not announced+4.5%
Apr 23, 2025Time not announced+4.1%
Feb 5, 2025Time not announced+1.4%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on BSXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on BSX
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on BSX

Technical Analysis

BSX · as of the Nov 20 close · updated each morning
Downtrend

The stock is 4% below its 20 day and 4% below its 50 day average. It is 26% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 42). The nearest support is the Pivot S1 at $41.52, and the nearest resistance the Pivot at $42.38.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 3.8%/day
Key levels
$101.9152 week high+142.8%
$53.07200 day average+26.4%
$45.45Swing high (Jul 16)+8.3%
$45.39100 day average+8.1%
$43.8450 day average+4.4%
$43.8220 day average+4.4%
$42.83Pivot R1+2.0%
$42.38Pivot+1.0%
$41.98Last close
$41.52Pivot S1−1.1%
$41.38Swing low (Oct 8)−1.4%
$39.5752 week low−5.7%
Indicators
RSI (14)41.57Middle of its rangeNeutral
MACD-0.32Below its signal lineBearish
Stochastic19.7Near the bottom of its rangeOversold
ADX (14)12.9No clear trend
Williams %R-98.8Oversold below −80, overbought above −20Oversold
CCI (20)-108.6Oversold below −100, overbought above 100Oversold
Rate of change−1.8%Change over 10 sessionsBearish
ATR (14)$1.58Typical daily range, 3.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for BSX

What happened before

See how BSX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow BSX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How BSX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for BSXHow many large options trades hit BSX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

BSX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●789 buying vs 735 selling
  • ●Held by funds +0.1 pts
  • ▲Funds holding +29
  • ▼Superinvestors: 1 added, 4 cut
  • ▼Put/call 0.25 to 0.34
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1,5161,487+2.0%
In funds' top 101011−9.1%
Held by funds92.3%92.2%+0.1 pts
New / increased217 / 572132 / 591+9.1%
Reduced / sold out555 / 180613 / 327−21.8%
Put/call ratio0.340.25+36.6%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BSX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

BSX Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$10.0M8 buys · 5 insiders
Sold$16.8M2 sales · 2 insiders
100% of the selling was under pre-arranged trading plans.
Cluster buy: 4 insiders bought $9.5M between Jul 31 and Aug 25.
2025-12 sold $1.8M2026-02 sold $15.0M2026-05 bought $554K2026-07 bought $227K2026-08 bought $9.3MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Aug 25Susan E MoranoDirectorBuy2,040$49.22$100K
Aug 5David C HabigerDirectorBuy2,100$47.59$100K
Aug 4David C HabigerDirectorBuy1,182$48.13$57K
Aug 3Michael F MahoneyChairman, President & CEOBuy186,240$48.33$9.0M
Jul 31Edward J LudwigDirectorBuy5,000$45.48$227K
May 20David C HabigerDirectorBuy4,450$56.43$251K
Every insider buy and sale for BSX over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See BSX insider trades →

From SEC Form 4 filings by BSX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

BSX Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
—
 
Left in program
$3.0B
4.9% of value
Shares outstanding, 12 months
−2.2%
Fewer shares
Last quarter
—
Sep 2026
Avg price paid, last quarter
—
 
S&P 500 rank by spending
—
 
Spent each quarter, last 3 yearsTop bar $2.0B
Dec 2023: $0Mar 2024: $0Jun 2024: $0Sep 2024: $0Dec 2024: $0Mar 2025: $0Jun 2025: $0Sep 2025: $0Dec 2025: $0Mar 2026: $0Jun 2026: $2.0B, average price $50.10Sep 2026: $0
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 2, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BSX is in one of them and how their past BSX trades turned out.

BSX in the AI portfolios
Loading…

BSX News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BSX in an article yet. Here's the latest on the wider market.

BSX in the news

BSX Congress Trades

All congress trades →
Trades, 12 months
26
Buys
13
50%
Sells
13
50%
People
6
Last filed Nov 5
Who traded BSX · since 2015
Latest 5 filings of 105
$1K – $15KTraded Oct 13, 2026Filed Nov 5, 2026
Ro KhannaSell (partial)
$1K – $15KTraded Oct 7, 2026Filed Nov 5, 2026
$1K – $15KTraded Sep 11, 2026Filed Oct 7, 2026
Ro KhannaSell (partial)
$1K – $15KTraded Sep 4, 2026Filed Oct 7, 2026
$50K – $100KTraded Sep 9, 2026Filed Sep 25, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$1K – $15KOct 13, 2026Nov 5, 202623 d
Ro KhannaD · CASell (partial)$1K – $15KOct 7, 2026Nov 5, 202629 d
Ro KhannaD · CASell$1K – $15KSep 11, 2026Oct 7, 202626 d
Ro KhannaD · CASell (partial)$1K – $15KSep 4, 2026Oct 7, 202633 d
Kevin HernR · OKSell$50K – $100KSep 9, 2026Sep 25, 202616 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Boston Scientific

Boston Scientific develops, manufactures and markets medical devices used in procedures across several areas of health care. Its products are mainly bought by hospitals, physicians and other health care providers around the world, who are usually reimbursed for those procedures by government programs and private health plans. The company is based in Marlborough, Massachusetts, in the United States, and it competes with large device makers as well as smaller firms that focus on a few products.

Headquarters
Marlborough, MA
Founded
1979